glp-1 deficiency The promise and peril of agonists: What we do (and don't) know as of August 2024 Why are GLP-1 agonists being

As changes in heat sensitivity are dependent on TRPV1 activity, we sought to determine whether intraplantar injection of 10 g of GLP-1(736) modulates spontaneous pain behavior induced by the TRPV1 agonist CAP in mice

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

Improved lab markers : Beyond weight, we typically see improvements in inflammatory markers, cholesterol values, and liver function testsreducing long-term health risks

Several other indications are under study, including obstructive sleep apnea, MASLD, knee osteoarthritis, chronic kidney disease, and cardiovascular outcomes

Convenience matters, but it should not replace medical judgment

While 20th century medical solutions for weight loss were marred by withdrawals, failures and death, surgical methods found success